VXTRF yields 6666666.89% · JNJ yields 2.13%● Live data
📍 VXTRF pulled ahead of the other in Year 1
Combined, VXTRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VXTRF + JNJ for your $10,000?
Voxtur Analytics Corp. operates as a real estate technology company. The company provides automated workflows and targeted data analytics to simplify tax solutions, property valuation, and settlement services for investors, lenders, government agencies, and mortgage servicers. Its solutions include Voxtur Assessment, Voxtur Valuation, Voxtur Settlement Services, and Voxtur Data & Insights. The company offers software that automates and digitizes the appraisal process, including order tracking, job assignment, collaboration, scheduling tools, and mobile apps for appraisers and enterprises; desktop review software for assessors and government agencies that generates customized portals to view multiple elements related to a property, including street level imagery, aerial imagery, building outline sketches, advanced mapping tools, property valuation details, comparable property analysis, and structural characteristics; software that analyzes the accuracy of property assessments to deliver comparable modeling and predictive valuations using proprietary algorithms; and real estate valuation solutions to deliver appraisal and broker price opinion services. It also provides property tax analysis and appeal management platform and sketch software; outsourced property-related services; real estate technology and non-legal default services; and full service title, escrow, and closing services. In addition, the company commercializes client data through the delivery of reports and individual data requests; and customized reports. It serves property lending and property tax sectors in the United States and Canada. The company was formerly known as iLOOKABOUT Corp. and changed its name to Voxtur Analytics Corp. in February 2021. Voxtur Analytics Corp. is headquartered in London, Canada.
Full VXTRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.